SAN CARLOS, Calif., June 30, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its Industrial Products Division has achieved the bioconversion of methane to farnesene in the lab with its proprietary platf ... ...

26 people liked this